SEARCH

SEARCH BY CITATION

References

  • 1
    Hadler SC. Global impact of hepatitis A virus infection changing patterns. In: HollingerFB, LenonSM, MargolisH eds. Viral hepatitis and liver disease. Baltimore, Md: Williams and Wilkins, 1991:1420.
  • 2
    Jong EC. Risks of hepatitis A and B in the traveling public. J Travel Med 2001; 8(Suppl 1):S38.
  • 3
    Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996; 45:130.
  • 4
    Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 49;1102.
  • 5
    Kane M. Global program for control of hepatitis B infection. Vaccine 1995; 13(Suppl 1):S4749.
  • 6
    Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination; recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991; 40:119.
  • 7
    Teitelbaum P. An estimate of the incidence of hepatitis A in unimmunized Canadian travelers to developing countries. J Travel Med 2004; 11:102106.
  • 8
    Steffen R. Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations. Vaccine 1993; 11:518520.
  • 9
    Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:663638. (Reference for risk for typhoid in travelers in introduction).
  • 10
    Barzaga NG. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000; 18:S6164.
  • 11
    Das K, Jain A, Gupta S, et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol 2000; 16:507510.
  • 12
    Lee A, Cheng F, Lau L, et al. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications? Public Health 1999; 113:185188.
  • 13
    Chin KP, Lok AS, Wong LS, et al. Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 1991; 34:191193.
  • 14
    Poovorawan Y, Theamboonlers A, Vimolkej T, et al. Prevalence of infection with hepatitis A virus among primary-school children in Bangkok, Thailand. Ann Trop Med Parasitol 1997; 1:119120.
  • 15
    Singhvi A, Pulimood RB, John TJ, et al. The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in South India. J Trop Med Hyg 1990; 93:178182.
  • 16
    Seiji K, Inoue O, Liu SJ, et al. Prevalence of hepatitis B virus infection markers among factory workers in Beijing, China. Asia Pac J Public Health 1991; 5:345349.
  • 17
    Li L, Jiaxin H, Zhao L, et al. Epidemiologic features of viral hepatitis in Fujian. Chin J Epidemiol 1998;19:89–92. [Abstract in English].
  • 18
    Dhawan PS, Shah SS, Alvares JF, et al. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine. Indian J Gastroenterol 1998; 17:1618.
  • 19
    Agarwal R, Naik S, Yachha SK, Naik SR. Seroprevalence of antibodies to hepatitis A virus among children in Northern India. Indian Pediatr 1999; 36:12481250.
  • 20
    Joshi N, Kumar N, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol 2000; 21:6365.
  • 21
    Mall ML, Rai RR, Philip M, et al. Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J Gastroenterol 2001; 20:132135.
  • 22
    Chen E, Yao J, Yang J, et al. Cost-benefit analysis for hepatitis A vaccine. Chin J Epidemiol 1999; 20:224227. [Abstract in English].
  • 23
    Das A. An economic analysis of different strategies of immunisation against hepatitis A virus in developed countries. Hepatology 1999; 29:548552.
  • 24
    Barnett ED, Holmes AH, Geltman P, et al. Immunity to hepatitis A in people born and raised in endemic areas. J Travel Med 2003; 10:1114.
  • 25
    Struve J, Norrbohm O, Stenbeck J, et al. Risk factors for hepatitis A, B and C virus infection among Swedish expatriates. J Infect 1995; 31:205209.
  • 26
    Tandon BN, Acharya SK, Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 1996; 38(Suppl 2):S5659.
  • 27
    Irshad M, Joshi YK, Acharya SK, et al. Prevalence of hepatitis B virus infection in healthy persons in North India. Natl Med J India 1994; 7:210212.
  • 28
    Nayak NC, Panda SK, Zuckerman AJ, et al. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987; 21:137145.
  • 29
    Centers for Disease Control and Prevention. Acute hepatitis B among children and adolescents—United States, 1990–2002. MMWR Morb Mortal Wkly Rep 2004; 53:10151018.